PTC Therapeutics to Participate at Upcoming Virtual Investor Conference PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Credit Suisse 30th Annual Healthcare...
Tuesday, October 26, 2021 BiopharmaWatch Research 1 min read
Key Takeaway: SOUTH PLAINFIELD, N.J. , Oct. 26, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that management will present a company overview at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, Nov. 9 at 8:00 a.m. ET .
The presentation will be webc
Price reaction · baseline $36.2 (2021-10-25 close) · hit after-hours · 1 other PTCT headline(s) in the window, move may be shared
day 0 close · peak
-1.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis
Full Press Release Details
SOUTH PLAINFIELD, N.J. , Oct. 26, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that management will present a company overview at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, Nov. 9 at 8:00 a.m. ET .
The presentation will be webcast live on the Events and Presentations page on the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.